CAR T Cells: Expanding into Multiple Myeloma



Results from two early-phase trials presented at the American Society of Clinical Oncology annual meeting suggest that an immunotherapy using genetically engineered immune cells may be effective in patients with advanced multiple myeloma.



Source link

Comments are closed.